AMBRX

Welcome to the Brand page for “AMBRX”, which is offered here for Biological and biochemical preparations for the treatment of cancer, protein expression systems consisting of amino acids, enzymes, rna molecules, and live cells for generating novel bio-therapeutics and optimizing the performance of bio-conjugated peptides, therapeutic proteins, monoclonal antibodies, and bi- and multi-specific medicines;.

Its status is currently believed to be active. Its class is unavailable. “AMBRX” is believed to be currently owned by “Ambrx, Inc.”